
Case Report Poster: A Smelly Situation
Key Takeaways
- A 38-year-old patient with schizoaffective disorder developed new olfactory hallucinations following transient anosmia/hypogeusia, alongside manic activation and delusional content.
- Standard neurologic and medical workup, including CT brain and labs, was unrevealing, whereas SARS-CoV-2 PCR was positive without other COVID-19 symptoms.
This case presented as part of the Poster Presentations at the 2021 NEI® Congress is a good reminder of the importance of taking a thorough history.
CONFERENCE REPORTER
Parul Kumar, MD, and colleagues from Westchester Medical Center,
The patient reported delusions of her father invisibly raping her. She also reported hypoguesia and
Neurological examination was within normal limits, as were brain computed tomography, chest X-ray, and various laboratory studies. However, the patient tested positive for SARS-CoV-2.
Following admission and treatment for 2 days that included aripiprazole, haloperidol, topiramate, and fluoxetine, the patient reported resolution of the hallucinations and was discharged to follow-up outpatient care.
Research has indicated that patients with schizophrenia have an increased risk for acquiring COVID-19, with an adjusted odds ratio of 7.34,1 along with increased risk for hospitalization (27.4% vs 18.6%) and mortality (8.5% vs 4.7%) compared with individuals with no psychiatric disorders, respectively. Kumar et al noted the olfactory symptoms were the only presenting symptoms associated with COVID-19 in their patient. Thus, they recommended testing for SARS-CoV-2 in patients with psychosis or other psychiatric illness who present with olfactory symptoms as part of the differential diagnosis.
Reference
1. Wang Q, Xu R, Volkow ND.
The articles and interviews featured on this page were developed by Psychiatric Times editorial staff and contributors based on presentations delivered at NEI® Congress, an annual conference produced by HMP Global. Psychiatric Times is an independent publication and is not affiliated with, endorsed by, or sponsored by any third-party. All content on this page reflects the independent editorial judgment of Psychiatric Times and does not represent the views, positions, or communications of any third-parties.











